NVO · NYSE
Novo Nordisk A (NVO) Stock Price & Fundamentals
$358.54+1.17%+$4.16End-of-day price as of Oct 9, 2026
Sample prices
Prices on this page are generated sample data for development, not real market data, so market cap, P/E and dividend yield are illustrative too.
Novo Nordisk A (NVO) closed at $358.54 on Oct 9, 2026, up 1.17% from the previous close of $354.38.
Share price, past year
1Y +29.84%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $358.54 |
| Sep 30, 2026 | $355.60 |
| Aug 31, 2026 | $340.42 |
| Jul 31, 2026 | $330.89 |
| Jun 30, 2026 | $318.60 |
| May 29, 2026 | $313.86 |
| Apr 30, 2026 | $307.96 |
| Mar 31, 2026 | $281.29 |
| Feb 27, 2026 | $279.08 |
| Jan 30, 2026 | $275.22 |
| Dec 31, 2025 | $269.45 |
| Nov 28, 2025 | $267.95 |
| Oct 31, 2025 | $287.12 |
Key statistics
- 52-week range
- $261.83 – $358.54
Financials
Novo Nordisk A reports to the SEC in international accounting standards (IFRS), which Laurel doesn't show yet.
Company profile
- Name
- Novo Nordisk A/S
- Ticker
- NVO
- Exchange
- NYSE
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- Novo Alle Dk 2880, Bagsvaerd Denmark, G7 00000
- Fiscal year ends
- December
- SEC CIK
- 0000353278
Frequently asked questions
What is Novo Nordisk A's stock price?
Novo Nordisk A (NVO) closed at $358.54 on Oct 9, 2026, up 1.17% from the previous close of $354.38.
Sources and methodology
Fundamentals come from Novo Nordisk A/S's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures